doi: 10.3390/ijms222011128 Summary Keywords non-alcoholic fatty liver disease, short-chain fatty acids, gut microbiota, glycolipid metabolism, therapy Citation Qin X, Chen M, He B, Chen Y and Zheng Y (2025) Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets
In the USA, AD is placed in third position after neoplasms and cardiovascular diseases concerning social security costs [31]
Mgarbane B, Oberlin M, Alvarez JC, Balen F, Beaune S, Bdry R, et al
MEDICAL DISCLAIMER : Educational content only
Enjoying the great outdoors is easy here
Five of these were global multicenter trials, and two regional studies were carried out in Japan